Company Profile
Vericel Corp Stock Price, News & Catalysts
- Ticker:
- VCEL
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
42.68 USD (+1.35%)
Close
Last updated: August 21, 2026
1.76B USD
Market cap
Why the stock is moving
As of Aug 21, 2026, VCEL closed up 1.35% at $42.68. No new same-company headline was identified in the current news window.
Company overview
Advanced Therapies for Sports Medicine and Burns
Vericel is a commercial-stage advanced therapies company serving the sports medicine and severe burn care markets. Its portfolio combines cell therapies and specialty biologics aimed at repairing injuries and restoring function.
MACI-Led Sports Medicine Franchise
MACI is Vericel's largest product and core growth driver. It is an autologous cellularized scaffold product used to repair symptomatic full-thickness cartilage defects of the knee in adults. Second-quarter 2026 MACI revenue grew 23%, supported by double-digit biopsy and implant growth and record second-quarter surgeon and procedure metrics.
Severe Burn Care Portfolio
Vericel's burn care business includes Epicel, a permanent skin replacement for severe burns, and NexoBrid, a biologic used for eschar removal in deep partial-thickness and full-thickness thermal burns. The burn care franchise grew 22% in the second quarter, with NexoBrid posting record quarterly revenue.
Strategic Position
Vericel is best understood as a profitable, commercial advanced-therapy company with two focused procedural franchises. Its differentiation comes from specialized biologic products, surgeon adoption, manufacturing scale, and clinical use in high-need repair settings.
Future catalysts
- MACI marketing authorization review in the United Kingdom.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Vericel Corp (VCEL)?
Vericel Corp (VCEL) most recently closed at 42.68 USD, a +1.35% move versus the previous session.
What is the market cap of Vericel Corp (VCEL)?
Vericel Corp currently has a market capitalization of 1.76B USD on BioPharmSignal.
What does Vericel Corp do?
Advanced Therapies for Sports Medicine and Burns Vericel is a commercial-stage advanced therapies company serving the sports medicine and severe burn care markets. Its portfolio combines cell therapies and specialty biologics aimed at repairing injuries and restoring function. MACI-Led Sports Medicine Franchise MACI is Vericel's largest product and core...
On which exchange is VCEL stock listed?
Vericel Corp (VCEL) is associated with NASDAQ, United States, Biopharma.
What is Advanced?
Advanced Therapies for Sports Medicine and Burns Vericel is a commercial-stage advanced therapies company serving the sports medicine and severe burn care markets.
Which conditions is Vericel Corp targeting with Advanced?
Advanced Therapies for Sports Medicine and Burns Vericel is a commercial-stage advanced therapies company serving the sports medicine and severe burn care markets. Its portfolio combines cell therapies and specialty biologics aimed at repairing injuries and restoring function. MACI-Led Sports Medicine Franchise MACI is Vericel's largest product and core...
How does Vericel Corp describe recent progress with Advanced?
MACI marketing authorization review in the United Kingdom.
What is Therapies?
Advanced Therapies for Sports Medicine and Burns Vericel is a commercial-stage advanced therapies company serving the sports medicine and severe burn care markets.